GenSight Biologics S.A. (SIGHT.PA)
EUR 0.23
(-1.95%)
EUR 0.23
(-1.95%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.54 EUR | 10.0% |
| 2022 | -0.60 EUR | 4.76% |
| 2021 | -0.63 EUR | 35.05% |
| 2020 | -0.97 EUR | 10.19% |
| 2019 | -1.08 EUR | 21.17% |
| 2018 | -1.37 EUR | -24.55% |
| 2017 | -1.10 EUR | 19.12% |
| 2016 | -1.36 EUR | -12.4% |
| 2015 | -1.21 EUR | -146.94% |
| 2014 | -0.75 EUR | -145.0% |
| 2013 | -0.32 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.04 EUR | 74.79% |
| 2024 Q2 | -0.04 EUR | 0.0% |
| 2023 Q3 | -0.14 EUR | 46.15% |
| 2023 Q1 | -0.13 EUR | 27.78% |
| 2023 Q4 | -0.14 EUR | 0.0% |
| 2023 FY | - EUR | 10.0% |
| 2023 Q2 | -0.26 EUR | -100.0% |
| 2022 Q4 | -0.18 EUR | 0.0% |
| 2022 Q3 | -0.18 EUR | 21.74% |
| 2022 Q1 | -0.12 EUR | 45.45% |
| 2022 Q2 | -0.23 EUR | -91.67% |
| 2022 FY | - EUR | 4.76% |
| 2021 FY | - EUR | 35.05% |
| 2021 Q2 | -0.19 EUR | -100.42% |
| 2021 Q4 | -0.22 EUR | 0.0% |
| 2021 Q1 | -0.09 EUR | 82.44% |
| 2021 Q3 | -0.22 EUR | -15.79% |
| 2020 Q2 | -0.43 EUR | -95.45% |
| 2020 Q3 | -0.26 EUR | 39.53% |
| 2020 Q4 | -0.54 EUR | -107.69% |
| 2020 FY | - EUR | 10.19% |
| 2020 Q1 | -0.22 EUR | 51.11% |
| 2019 Q3 | -0.23 EUR | 63.49% |
| 2019 Q2 | -0.63 EUR | -103.23% |
| 2019 Q1 | -0.31 EUR | 65.17% |
| 2019 FY | - EUR | 21.17% |
| 2019 Q4 | -0.45 EUR | -95.65% |
| 2018 Q1 | -0.24 EUR | 17.24% |
| 2018 Q3 | -0.44 EUR | 8.33% |
| 2018 Q4 | -0.89 EUR | -102.27% |
| 2018 FY | - EUR | -24.55% |
| 2018 Q2 | -0.48 EUR | -100.0% |
| 2017 Q4 | -0.29 EUR | 0.0% |
| 2017 Q1 | -0.26 EUR | 23.53% |
| 2017 FY | - EUR | 19.12% |
| 2017 Q2 | -0.26 EUR | 0.0% |
| 2017 Q3 | -0.29 EUR | -11.54% |
| 2016 Q1 | -0.34 EUR | -3.03% |
| 2016 Q3 | -0.34 EUR | 0.0% |
| 2016 Q2 | -0.34 EUR | 0.0% |
| 2016 Q4 | -0.34 EUR | 0.0% |
| 2016 FY | - EUR | -12.4% |
| 2015 Q3 | -0.33 EUR | -26.92% |
| 2015 Q4 | -0.33 EUR | 0.0% |
| 2015 FY | - EUR | -146.94% |
| 2015 Q2 | -0.26 EUR | 0.0% |
| 2015 Q1 | -0.26 EUR | -8.33% |
| 2014 Q4 | -0.24 EUR | 0.0% |
| 2014 FY | - EUR | -145.0% |
| 2014 Q1 | -0.14 EUR | 0.0% |
| 2014 Q3 | -0.24 EUR | -71.43% |
| 2014 Q2 | -0.14 EUR | 0.0% |
| 2013 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -350.0% |
| ABIVAX Société Anonyme | -3.43 EUR | 84.257% |
| Adocia SA | -1.91 EUR | 71.728% |
| Aelis Farma SA | -0.39 EUR | -38.462% |
| Biophytis S.A. | -12.55 EUR | 95.697% |
| Advicenne S.A. | -0.67 EUR | 19.403% |
| genOway Société anonyme | 0.17 EUR | 417.647% |
| IntegraGen SA | -0.03 EUR | -1984.942% |
| Medesis Pharma S.A. | -0.80 EUR | 32.5% |
| Neovacs S.A. | -0.00 EUR | -21500.0% |
| NFL Biosciences SA | -0.46 EUR | -17.391% |
| Plant Advanced Technologies SA | 0.07 EUR | 871.429% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -493.407% |
| Sensorion SA | -0.17 EUR | -217.647% |
| Theranexus Société Anonyme | -0.88 EUR | 38.636% |
| TME Pharma N.V. | -1.34 EUR | 59.701% |
| Valbiotis SA | -0.59 EUR | 8.475% |
| TheraVet SA | -0.49 EUR | -10.204% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -260.0% |
| DBV Technologies S.A. | -0.71 EUR | 23.944% |
| Genfit S.A. | -0.58 EUR | 6.897% |
| GeNeuro SA | -0.59 EUR | 8.475% |
| Innate Pharma S.A. | -0.09 EUR | -473.858% |
| Inventiva S.A. | -2.43 EUR | 77.778% |
| MaaT Pharma SA | -1.73 EUR | 68.786% |
| MedinCell S.A. | -0.88 EUR | 38.636% |
| Nanobiotix S.A. | -1.08 EUR | 50.0% |
| OSE Immunotherapeutics SA | -1.18 EUR | 54.237% |
| Poxel S.A. | -0.91 EUR | 40.659% |
| Transgene SA | -0.22 EUR | -145.455% |
| Valneva SE | -0.73 EUR | 26.027% |